Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemoglobin subunit epsilon 1 (HBE1) encodes the epsilon chain—a beta-like globin chain that is expressed exclusively during early mammalian embryonic development in the yolk sac. The protein forms part of embryonic hemoglobin types (Hb Gower I and Hb Gower II), combining with zeta or alpha-globin chains for early oxygen transport before the fetal and adult hemoglobins (HBG, HBB, HBD) predominate. The gene belongs to the beta-globin gene cluster located on chromosome 11 (11p15.5), alongside gamma, delta, and beta globin genes; its expression is tightly developmentally regulated and silenced after the embryonic period. Mutations in HBE1 are rare and not associated with major adult disease phenotypes; some rare hemoglobinopathies (e.g., thalassemias) may mention variant embryonic globin expression, but this is of limited clinical significance.
Not applicable; there are no drugs known to target this subunit specifically
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin subunit epsilon 1 (HBE1).